← FDA Drug Approvals (Drugs@FDA)
MIRTAZAPINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PRASCO · Approved 2023-01-18
Drug application
- FDA Application #
ANDA216751- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- MIRTAZAPINE
- Generic name
- MIRTAZAPINE
- Active ingredients
- MIRTAZAPINE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- PRASCO
- Manufacturer
- Prasco Laboratories
- First approval
- 2023-01-18
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown